Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01211041
Other study ID # 99026
Secondary ID
Status Recruiting
Phase N/A
First received September 28, 2010
Last updated April 21, 2011
Start date July 2010
Est. completion date July 2011

Study information

Verified date April 2011
Source Taipei Medical University WanFang Hospital
Contact Tsong-Yih Ou
Phone 886-2-29307930
Email 93023@wanfang.gov.tw
Is FDA regulated No
Health authority Taiwan: Department of Health
Study type Observational

Clinical Trial Summary

Candida albicans is the most common and important clinical fungal pathogen. Our previous surveillance disclosed that fluconazole could induce different morphological changes in clinical strains. Our current study on C. albicans causing candiuria disclosed that renal insufficiency , diabetes mellitus, respiratory failure and uremia were risk factors of treatment failure. However, we also found results of E-test drug susceptible test could not predict outcome. Hence, retrospective analysis of 31 months period, cases that had C. albicans inducing candidemia were reviewed and 60 cases were enrolled for morphological study and potential virulent gene analysis.

This study is designed to clarity the clinical meaning of morphological form and virulent genes on candidemia. To do this study is probably helpful for treatment of candidiasis.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date July 2011
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- 2007 to 2010 medical records

- Cases with candidemmia of Candida albicans with available clinical information in medical records for analysis.

- Cases with candidemmia of Candida albicans which clinical isolates were preserved.

Exclusion Criteria:

- Cases were not hospitalized for treatment and data were not available for analysis.

Study Design

Observational Model: Case-Only, Time Perspective: Retrospective


Related Conditions & MeSH terms


Locations

Country Name City State
Taiwan Taipei Medical University - WanFang Hospital Taipei

Sponsors (1)

Lead Sponsor Collaborator
Taipei Medical University WanFang Hospital

Country where clinical trial is conducted

Taiwan,